# Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHD

> **NCT00305370** · PHASE4 · COMPLETED · sponsor: **Federal University of Rio Grande do Sul** · enrollment: 20 (estimated)

## Conditions studied

- Bipolar Disorder
- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Aripiprazole

## Key facts

- **NCT ID:** NCT00305370
- **Lead sponsor:** Federal University of Rio Grande do Sul
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2008-01
- **Final completion:** 2008-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2008-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00305370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00305370, "Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHD". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00305370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*